PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
31.29%
Some net income increase while RRC is negative at -72.32%. John Neff would see a short-term edge over the struggling competitor.
6.89%
D&A growth well above RRC's 0.52%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
-0.42%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
No Data
No Data available this quarter, please select a different quarter.
-400.77%
Both reduce yoy usage, with RRC at -51.58%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative yoy usage while RRC is 44.92%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-5042.90%
Negative yoy while RRC is 58.51%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-29.47%
Both yoy CFO lines are negative, with RRC at -11.22%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-25.08%
Negative yoy CapEx while RRC is 31.41%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
100.00%
Acquisition growth of 100.00% while RRC is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-62.03%
Both yoy lines negative, with RRC at -5125.03%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-72.10%
Both yoy lines negative, with RRC at -315.08%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-3.15%
We cut debt repayment yoy while RRC is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
132.61%
Stock issuance far above RRC's 147.10%. Michael Burry flags a significant dilution risk vs. competitor’s approach unless ROI is very high.
68.97%
Buyback growth of 68.97% while RRC is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.